Update on Inflammation, Neurodegeneration, and Immunoregulation in Multiple Sclerosis
Calcium Homeostasis Is Dysregulated in Parkinsonian Patients With l-DOPA-Induced Dyskinesias
Pharmacokinetic and Pharmacodynamic Comparison of Ropinirole 24-Hour Prolonged Release and Ropinirole Immediate Release in Patients With Parkinson's Disease
Efficacy and Tolerability of Aripiprazole in First-Episode Drug-Naive Patients With Schizophrenia
Moclobemide Treatment of Clozapine-Induced Hypersalivation
N-Desmethylclozapine
Successful Treatment of REM Sleep Behavior Disorder With Sodium Oxybate
Temporal Lobe Epilepsy Confused With Panic Disorder
Pain in Progressive Supranuclear Palsy
Botulinum Toxin in Painful Tardive Dyskinesia
Syndrome of Inappropriate Antidiuretic Hormone Secretion Possibly Associated With Amantadine Therapy in Parkinson Disease
Oxcarbazepine Treatment of Restless Legs Syndrome
Inappropriate Conclusions From the Use of Botulinum Toxin for the Treatment of Spasticity
Response
Adjunctive Pregabalin to Quetiapine in Acute Mania
High-Dose Duloxetine for Treatment-Resistant Obsessive-Compulsive Disorder
Fluvoxamine in the Treatment of Corticosteroid-Induced Obsessive-Compulsive Disorder
Methylphenidate and Psychotic Depression
Improvement of Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction Without Worsening of Depressive Symptom After Switching to Milnacipran